Identification of point mutations and large rearrangements in the BRCA1 gene in 667 Turkish unselected ovarian cancer patients

Gynecologic Oncology

Volumn 119, Issue 1, 2010, Pages 131-135

  Aktas, D ^a   Gultekin, M ^a   Kabacam, S ^a   Alikasifoglu, M ^a   Turan, A T ^b   Tulunay, G ^b   Kose, M F ^b   Ortac, F ^c   Yuce K ^a   Tuncbilek E ^a   Ayhan, A ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Etlik Zubeyde Hanim Women's Health Teaching and Research Hospital   (Turkey)

^c GÜVEN HOSPITAL   (Turkey)

Author keywords

BRCA1; Breast cancer; Gene; Ovarian cancer; Turkey

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CONTROLLED STUDY; EXON; FAMILY ASSESSMENT; FAMILY HISTORY; FEMALE; GENE REARRANGEMENT; GENETIC CODE; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; OUTCOME ASSESSMENT; OVARY CANCER; POINT MUTATION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RNA SPLICING; TUMOR SUPPRESSOR GENE; TURKEY (REPUBLIC); BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; GENETICS; MIDDLE AGED; MULTICENTER STUDY; OVARY TUMOR; TURKEY;

CASE-CONTROL STUDIES; DNA, NEOPLASM; FEMALE; GENE REARRANGEMENT; GENES, BRCA1; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; POINT MUTATION; TURKEY;

DNA;

EID: 77956651425     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.05.018     Document Type: Article

References (27)

1. A.R. Venkitaraman Cancer susceptibility and the functions of BRCA1 and BRCA2 Cell 108 2002 171 182
2. E.B. Claus, J.M. Schildkraut, W.D. Thompson, and N.J. Risch The genetic attributable risk of breast and ovarian cancer Cancer 77 1996 2318 2324
3. T.R. Rebbeck, N.D. Kauff, and S.M. Domchek Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers J Natl Cancer Inst 101 2009 80 87
4. C.R. Ferrone, D.A. Levine, L.H. Tang, P.J. Allen, W. Jarnagin, and M.F. Brennan BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma J Clin Oncol 27 2009 433 438
5. T. Distelman-Menachem, T. Shapira, Y. Laitman, B. Kaufman, F. Barak, and S. Tavtigian Analysis of BRCA1/BRCA2 genes' contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women Fam Cancer 8 2009 127 133
6. S. Engert, B. Wappenschmidt, B. Betz, K. Kast, M. Kutsche, and H. Hellebrand MLPA screening in the BRCA1 gene from 1, 506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases Hum Mutat 29 2008 948 958
7. T.O. Hansen, L. Jønson, A. Albrechtsen, M.K. Andersen, B. Ejlertsen, and F.C. Nielsen Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families Breast Cancer Res Treat 115 2009 315 323
8. S. Palanca Suela, E. Esteban Cardeñosa, E. Barragán González, S. Oltra Soler, I. de Juan Jiménez, and I. Chirivella González Group for Assessment of Hereditary Cancer of Valencia Community. Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family Breast Cancer Res Treat 112 2008 63 67
9. M. Ratajska, I. Brozek, E. Senkus-Konefka, J. Jassem, M. Stepnowska, and G. Palomba BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland Oncol Rep 19 2008 263 268
10. A.E. Manguoglu, G. Lüleci, T. Ozçelik, T. Colak, H. Schayek, and M. Akaydin Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients Hum Mutat 21 2003 444 445
11. H. Ozdag, M. Tez, I. Sayek, M. Müslümanoglu, O. Tarcan, and F. Içli Germ line BRCA1 and BRCA2 gene mutations in Turkish breast cancer patients Eur J Cancer 36 2000 2076 2082
12. H. Yazici, O. Bitisik, E. Akisik, N. Cabioglu, P. Saip, and M. Muslumanoglu BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients Br J Cancer 83 2000 737 742
13. A. Balci, P. Huusko, K. Pääkkönen, V. Launonen, A. Uner, and A. Ekmekçi Mutation analysis of BRCA1 and BRCA2 in Turkish cancer families: a novel mutation BRCA2 3414del4 found in male breast cancer Eur J Cancer 35 1999 707 710
14. U. Egeli, G. Cecener, B. Tunca, and I. Tasdelen Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives Cancer Invest 24 2006 484 491
15. H. Yazici, G. Glendon, H. Yazici, S.J. Burnie, P. Saip, and F. Buyru BRCA1 and BRCA2 mutations in Turkish familial and non-familial ovarian cancer patients: a high incidence of mutations in non-familial cases Hum Mutat 20 2002 28 34
16. P.C. Chan, B.Y. Wong, H. Ozcelik, and D.E. Cole Simple and rapid detection of BRCA1 and BRCA2 mutations by multiplex mutagenically separated PCR Clin Chem 45 1999 1285 1287
17. H.A. Risch, J.R. McLaughlin, D.E. Cole, B. Rosen, L. Bradley, and E. Kwan Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer Am J Hum Genet 68 2001 700 710
18. J.F. Stratton, S.A. Gayther, P. Russell, J. Dearden, M. Gore, and P. Blake Contribution of BRCA1 mutations to ovarian cancer N Engl J Med 336 1997 1125 1130
19. T. Pal, J. Permuth-Wey, J.A. Betts, J.P. Krischer, J. Fiorica, and H. Arango BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases Cancer 104 2005 2807 2816
20. D. Abeliovich, L. Kaduri, I. Lerer, N. Weinberg, G. Amir, and M. Sagi The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women Am J Hum Genet 60 1997 505 514
21. E.N. Suspitsin, N.Y. Sherina, D.N. Ponomariova, A.P. Sokolenko, A.G. Iyevleva, and T.V. Gorodnova High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients Hered Cancer Clin Pract 7 2009 5
22. M. Ratajska, I. Brozek, E. Senkus-Konefka, J. Jassem, M. Stepnowska, and G. Palomba BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland Oncol Rep 19 2008 263 268
23. S. Engert, B. Wappenschmidt, B. Betz, K. Kast, M. Kutsche, and H. Hellebrand MLPA screening in the BRCA1 gene from 1, 506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases Hum Mutat 29 2008 948 958
24. S. Armaou, M. Pertesi, F. Fostira, G. Thodi, P.S. Athanasopoulos, and S. Kamakari Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases Br J Cancer 101 2009 32 37
25. S.L. Neuhausen, S. Mazoyer, L. Friedman, M. Stratton, K. Offit, and A. Caligo Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study Am J Hum Genet 58 1996 271 280
26. M.T. Valarmathi A A, Doe SS, Shula NK, Das SN. BRCA1 germline mutations in Indian familial breast cancer Hum Mutat 21 2003 98 99
27. N. Puget, S. Gad, L. Perrin-Vidoz, O.M. Sinilnikova, D. Stoppa-Lyonnet, and G.M. Lenoir Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot Am J Hum Genet 70 2002 858 865